Dr. Christopher M. Low, M.D.
ENT (Otolaryngology) (Otolaryngology Physician)
5841 S Maryland Ave
Chicago, IL 60637
Who else practices at this address →
Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Loyola University of Chicago, Stritch School of Medicine (2016)
- Years since graduation
- 10
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 516
Licensed in Illinois since 2022, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Medical school: Loyola University of Chicago, Stritch School of Medicine
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Otolaryngology Physician primary
IL license 036159966 (first issued 2022; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- The University of Chicago Medical Center Chicago, IL
- Ingalls Memorial Hospital Harvey, IL
Medical groups
- University of Chicago (1,712 clinicians)
- The University of Chicago Medical Center (915 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 516
- Services billed
- 1,230
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 373 | 299 |
| Removal of impacted ear wax | 184 | 164 |
| New patient office or other outpatient visit, 30-44 minutes | 156 | 156 |
| Diagnostic exam of nasal passages using an endoscope | 134 | 95 |
| Exam of ear using a microscope | 111 | 93 |
| Established patient office or other outpatient visit, 30-39 minutes | 82 | 73 |
| Diagnostic exam of voice box using a flexible endoscope | 74 | 68 |
| New patient office or other outpatient visit, 45-59 minutes | 66 | 66 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 52 | 52 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 23 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Azelastine Hcl Other prescribers in Chicago, IL | 242 |
| Fluticasone Propionate Other prescribers in Chicago, IL | 173 |
| Ipratropium Bromide Other prescribers in Chicago, IL | 101 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Chicago, IL | 35 |
| Omeprazole Other prescribers in Chicago, IL | 30 |
| Mupirocin Other prescribers in Chicago, IL | 27 |
| Montelukast Sodium Other prescribers in Chicago, IL | 21 |
| Pantoprazole Sodium Other prescribers in Chicago, IL | 19 |
| Oxycodone Hcl Other prescribers in Chicago, IL | 17 |
| Ciprofloxacin-Dexamethasone (ciprofloxacin hcl/dexameth) | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 10 payments worth $534 in total to this clinician.
| Medtronic, Inc. | $253 |
|---|---|
| Aerin Medical Inc. | $128 |
| Abiomed | $109 |
| Regeneron Pharmaceuticals, Inc. | $27.94 |
| Stryker Corporation | $15.55 |
| Food and Beverage | $534 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $36,400 in research payments for these studies, mostly to the institutions running them.
- A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
Sanofi US Services Inc. · Active, not recruiting · NCT06834347
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.